The Melding of Drug Screening Platforms for Melanoma.

Couto, Gabriela Klein; Segatto, Natália Vieira; Oliveira, Thaís Larré; Seixas, Fabiana Kömmling; Schachtschneider, Kyle M; Collares, Tiago

Couto, Gabriela Klein; Segatto, Natália Vieira; Oliveira, Thaís Larré; Seixas, Fabiana Kömmling; Schachtschneider, Kyle M; Collares, Tiago.

Afiliación

Couto GK; Research Group in Molecular and Cellular Oncology, Postgraduate Program in Biochemistry and Bioprospecting, Cancer Biotechnology Laboratory, Center for Technological Development, Federal University of Pelotas, Pelotas, Brazil.
Segatto NV; Biotechnology Graduate Program, Molecular and Cellular Oncology Research Group, Laboratory of Cancer Biotechnology, Technology Development Center, Federal University of Pelotas, Pelotas, Brazil.
Oliveira TL; Biotechnology Graduate Program, Molecular and Cellular Oncology Research Group, Laboratory of Cancer Biotechnology, Technology Development Center, Federal University of Pelotas, Pelotas, Brazil.
Seixas FK; Biotechnology Graduate Program, Molecular and Cellular Oncology Research Group, Laboratory of Cancer Biotechnology, Technology Development Center, Federal University of Pelotas, Pelotas, Brazil.
Schachtschneider KM; Department of Radiology, University of Illinois at Chicago, Chicago, IL, United States.
Collares T; Department of Biochemistry & Molecular Genetics, University of Illinois at Chicago, Chicago, IL, United States.

Front Oncol ; 9: 512, 2019.

Article en En | MEDLINE | ID: mdl-31293965

Palabras clave

3R; B16 melanoma; cancer; drug screening; in silico; in vitro; in vivo; melanoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google